AbelZeta Regains C-CAR039 Rights After FDA IND Clearance
Rockville, Maryland and Shanghai, China, August 17, 2026 AbelZeta Pharma, Inc. announced that the U.S. Food and Drug Administration...
Drug Delivery Technology
Advertisement
Lantheus Wins FDA Approval for Tau PET Agent in Alzheimer’s
Bedford, Massachusetts, August 14, 2026 Lantheus Holdings, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved...
BioSapien Nominated for 2026 Prix Galien Best Startup Award
San Diego, California, August 14, 2026 BioSapien Inc., a biotechnology company developing localized drug-delivery technologies for cancer treatment, has...
Dyne Secures FDA IND Clearance for DYNE-302 in FSHD
Waltham, Massachusetts, July 28, 2026 Dyne Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has cleared...
Vector, Wynn Partner on Critical Care Drug Delivery
Mequon, Wisconsin & Lenexa, Kansas, July 28, 2026 Vector Science & Therapeutics Corp., LyoGenesis Plus 1, LLC, and Wynn...
Advertisements
Galmed Advances Brain-Targeted Aramchol for Parkinson’s
Ramat-Gan, Israel, July 28, 2026 Galmed Pharmaceuticals Ltd. has announced a significant advancement in the development of Aramchol orally...
Biohaven Unveils Promising BHV-1530 Cancer Data at ESMO
NEW HAVEN, Conn., July 20, 2026 Biohaven Ltd. has announced that new Phase I clinical data for BHV-1530, its...
Halozyme and Incyte Join Forces to Improve Cancer Drug Delivery
SAN DIEGO, July 20, 2026 Halozyme Therapeutics has entered into a global collaboration and license agreement with Incyte to...
SNIS 2026 Unveils AI Breakthrough in Brain Tumor Treatment
SEATTLE, July 20, 2026 The Society of NeuroInterventional Surgery (SNIS) has unveiled a series of groundbreaking scientific presentations for...
Gilead’s Once-Weekly Yeztugo Accepted by FDA for HIV Prevention Review
FOSTER CITY, Calif., June 16, 2026 Gilead Sciences has announced that the U.S. Food and Drug Administration (FDA) has...
Advertisement
